Private Placement Form 8 K

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

On December 10, 2024 (the "Closing Date"), Sight Sciences, Inc. (the "Company") consummated the drawdown of the $5.0 million Tranche 1(b) Term Loan Advance (the "Tranche Loan") contemplated by that certain Loan and Security Agreement (the "Loan Agreement") by and among the Company, Hercules Capital, Inc. ("Hercules") and certain affiliates of Hercules (collectively with Hercules, the "Lenders"). The Loan Agreement provides for a senior secured term loan facility in the aggregate original principal amount of up to $65.0 million (the "Term Loan Facility"). Upon consummation of the Tranche Loan, the aggregate principal amount of borrowings under the Loan Agreement was $40.0 million.

The Term Loan Facility has a maturity date of July 1, 2028 (the "Maturity Date"). Upon repayment of the balance under the Term Loan Facility (whether at Maturity Date or upon earlier prepayment), the Company is required to pay an exit fee equal to 5.95% of the funded amounts under the Term Loan Facility. The Term Loan Facility will accrue interest at a floating annual rate based on the greater of (i) 10.35%, or (ii) the Wall Street Journal prime rate plus 2.35%. Accrued interest on the Term Loan Facility is payable monthly in arrears.

The proceeds of the Tranche Loan are intended to be used for general corporate purposes. The decision to consummate the Tranche Loan drawdown is consistent with the Company's capitalization strategy under which it plans to continue to achieve cash flow breakeven without the need to raise additional equity capital.

The Loan Agreement was previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on January 23, 2024.